P

Inventor

LIVERTON NIGEL J

US45 patents
⚠️ This page may combine multiple inventors who share the name “LIVERTON NIGEL J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

24 patents
US5859041AJan 12, 1999

Substituted imidazoles having cytokine inhibitory activity

MERCK & CO INC135 citations98
US5717100AFeb 10, 1998

Substituted imidazoles having anti-cancer and cytokine inhibitory activity

MERCK & CO INC116 citations98
US7470664B2Dec 30, 2008

HCV NS3 protease inhibitors

MERCK & CO INC81 citations97
US5837719ANov 17, 1998

2,5-substituted aryl pyrroles, compositions containing such compounds and methods of use

MERCK & CO INC77 citations96
US5792778AAug 11, 1998

2-substituted aryl pyrroles, compositions containing such compounds and methods of use

MERCK & CO INC63 citations96
US6083949AJul 4, 2000

Substituted imidazoles having anti-cancer and cytokine inhibitory activity

MERCK & CO INC28 citations93
US6870055B2Mar 22, 2005

Isoquinolinone potassium channels inhibitors

MERCK & CO INC28 citations92
US6376530B1Apr 23, 2002

Cyclic amidines useful as NMDA NR2B antagonists

MERCK & CO INC22 citations92
US6316474B1Nov 13, 2001

2-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonists

MERCK & CO INC43 citations92
US6207687B1Mar 27, 2001

Substituted imidazoles having cytokine inhibitory activity

MERCK & CO INC21 citations92
US6319944B1Nov 20, 2001

Aryl amidines, compositions containing such compounds and methods of use

MERCK & CO INC21 citations90
US7592360B2Sep 22, 2009

3-fluoro-piperidines as NMDA/NR2B antagonists

MERCK & CO INC18 citations84
US6403596B1Jun 11, 2002

Substituted pyridones having cytokine inhibitory activity

MERCK & CO INC14 citations84
US7259157B2Aug 21, 2007

N-substituted nonaryl-heterocyclo amidyl NMDA/NR2B Antagonists

MERCK & CO INC12 citations83
US7053089B2May 30, 2006

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

MERCK & CO INC13 citations82
US6492516B1Dec 10, 2002

Compounds having cytokine inhibitory activity

MERCK & CO INC9 citations74
US7217716B2May 15, 2007

N-substituted nonaryl-heterocyclic NMDA/NR2B antagonists

MERCK & CO INC8 citations72
US7196095B2Mar 27, 2007

(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds

MERCK & CO INC8 citations71
US6838291B2Jan 4, 2005

Radioligand and binding assay

MERCK & CO INC8 citations71
US6767908B2Jul 27, 2004

Substituted imidazoles having cytokine inhibitory activity

MERCK & CO INC4 citations63
US6602872B1Aug 5, 2003

Substituted pyridazines having cytokine inhibitory activity

MERCK & CO INC1 citations52
US6214823B1Apr 10, 2001

Benzodiazepine derivatives as antiarrhythmic agents

MERCK & CO INC1 citations52
US6291457B1Sep 18, 2001

Compounds having cytokine inhibitory activity

MERCK & CO INC1 citations51
US6440976B2Aug 27, 2002

Iminopyrimidine NMDA NR2B receptor antagonists

MERCK & CO INC0 citations42

MERCK SHARP & DOHME

8 patents

LIVERTON NIGEL J

4 patents

MCCOMAS CASEY C

3 patents

HARPER STEVEN

2 patents

HOLLOWAY M KATHARINE

2 patents

MCCAULEY JOHN A

1 patent

BOLEA CHRISTELLE

1 patent